About: Long-term benefit of dobutamine in patients with congestive cardiomyopathy

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Long-term benefit of dobutamine in patients with congestive cardiomyopathy Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 November 1980

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в листопаді 1980 (uk) im November 1980 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en payares de 1980 (ast) scientific article published on 01 November 1980 (en)
publication date	wds:Q71527026-B522D387-3431-4046-BEDF-D5BB06DB994D
publication date	1980-11-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q71527026-89215DB5-8961-4193-95E5-74A19A96730D
language of work or name	English
author name string	wds:Q71527026-0692B116-D97D-4DF3-846C-26C6EDF7C301 wds:Q71527026-4BEB781A-AD2D-465F-A4E3-77F0D1EC85FE wds:Q71527026-8115EAE7-1040-4711-930D-568777E06077 wds:Q71527026-8C893F6D-5761-403F-984E-17880B937CDA
author name string	C V Leier D V Unverferth R D Magorien R P Lewis
rdfs:label	Long-term benefit of dobutamine in patients with congestive cardiomyopathy (en) Long-term benefit of dobutamine in patients with congestive cardiomyopathy (nl)
skos:prefLabel	Long-term benefit of dobutamine in patients with congestive cardiomyopathy (en) Long-term benefit of dobutamine in patients with congestive cardiomyopathy (nl)
name	Long-term benefit of dobutamine in patients with congestive cardiomyopathy (en) Long-term benefit of dobutamine in patients with congestive cardiomyopathy (nl)
title	wds:Q71527026-3C3C7538-05A4-4D77-A5F0-6463B8B04445
title	Long-term benefit of dobutamine in patients with congestive cardiomyopathy (en)
page(s)	wds:Q71527026-E8207DCE-E804-43DE-B4AB-11E14249AD28
page(s)	622-630
instance of	wds:Q71527026-9827F055-B487-4D42-BAF1-BD60F46C8541
instance of	scholarly article
main subject	wds:Q71527026-1A59D830-15B7-44E7-B32D-30AE80256283
main subject	cardiomyopathy
PubMed ID	wds:Q71527026-98201941-56E7-4AD9-A127-D5BC7563F711
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6778182
PubMed ID	6778182
published in	wds:Q71527026-E565A719-339B-4309-BEBD-00874FC5970F
published in	American Heart Journal
issue	wds:Q71527026-0381B3DD-F3A9-48E1-85F0-7293496D2C6F
volume	wds:Q71527026-C0420B66-A51C-47C6-939C-607B5B35E6E4
issue	5
volume	100
DOI	wds:Q71527026-DF6EC1BD-105E-46ED-994F-E68D653A261A
DOI	http://dx.doi.org/10.1016/0002-8703(80)90226-4
DOI	10.1016/0002-8703(80)90226-4
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q71527026
is cites work of	Continuous home ambulatory intravenous inotropic drug therapy in severe heart failure: safety and cost efficacy Management of acute decompensated heart failure Prevention of bedrest-induced physical deconditioning by daily dobutamine infusions. Implications for drug-induced physical conditioning Rational use of inotropic therapy in heart failure Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST). The role of anti-cytokine therapy in the failing heart THE ROLE OF CYTOKINES IN THE FAILING HUMAN HEART Effects of dobutamine on left ventricular performance in newborns as determined by systolic time intervals The role of subendocardial ischemia in perpetuating myocardial failure in patients with nonischemic congestive cardiomyopathy Outpatient parenteral inotropic therapy for advanced heart failure The case against outpatient parenteral inotropic therapy for advanced heart failure Intermittent infusion of dobutamine in the therapy of severe congestive heart failure--long-term effects and lack of tolerance Intermittent dobutamine treatment in patients with chronic refractory congestive heart failure: a randomized, double-blind, placebo-controlled study Corticosteroid effect on early beta-adrenergic down-regulation during circulatory shock: hemodynamic study and beta-adrenergic receptor assay Efficacy of inotropic support of the failing heart Intermittent, continuous outpatient dobutamine infusion in the management of congestive heart failure Is there a role for positive inotropic agents in congestive heart failure: focus on mortality Inotrope use and outcomes among patients hospitalized for heart failure: impact of systolic blood pressure, cardiac index, and etiology Outpatient Dobutamine Therapy: The Rhyme and the Riddle Inotropic therapy of the failing myocardium Dobutamine stress echocardiography: a new, noninvasive method for detecting ischemic heart disease Positive inotropic therapy: an update and new agents Bridging to heart transplantation: prostaglandin E1 versus prostacyclin versus dobutamine Congestive heart failure. New frontiers Role of nonglycosidic inotropic agents: indications, ethics, and limitations Parenteral inotropic support for advanced congestive heart failure Inotropic agents. Catecholamines, digoxin, amrinone. Acute heart failure management in the USA and Japan: overview of practice patterns and review of evidence. Rad GTPase deletion attenuates post-ischemic cardiac dysfunction and remodeling [The clinical practice guidelines of the Sociedad Española de Cardiología on cardiomyopathies and myocarditis] Short- and long-term dobutamine treatment in chronic ischemic heart failure Quality of life and long-term mortality in patients with advanced chronic heart failure treated with intermittent low-dose intravenous inotropes in an outpatient setting Effect of medical therapy on survival of patients with dilated cardiomyopathy Pediatric chest pain: Case report of a malignant cause Refractory heart failure
is cites work of	wds:Q34561584-F7C69239-724F-40DC-B0BE-37ECB6DE0B4C wds:Q34223016-3C2C4696-575B-4E1B-8C84-700FB752FBF2 wds:Q37507556-DCE60A43-66FA-47EE-BC43-EFD33B26CD7D wds:Q71657504-3224B53B-DC3A-451A-90E4-2F5EDF033EEE wds:Q74776183-F50DFD85-377F-4A58-957C-50656A375617 wds:Q28293706-42821856-C978-4CBB-8244-59E64496A37A wds:Q35077700-24C48C6A-5074-4516-8267-8F67AADF491A wds:Q35659776-94996E5D-483D-4743-AD9E-03BBCA7B0380 wds:Q33559075-FD66F233-3D20-4D8D-A9C2-B13C9C7A30D6 wds:Q35106474-3E2B1300-51E0-4CCA-B515-0A8A7AC8EC51 wds:Q59192161-DC88BF4B-8B4E-4322-9366-E47FA9908031 wds:Q64993049-8E7528AB-307E-405A-8D7A-287EE544FB07 wds:Q62815342-B457178A-E68E-4726-A8B7-F93D5A1C2B19 wds:Q40867374-B538D00E-77BB-4B6A-94A7-9F2B47E282BE wds:Q36244456-EE48594B-0BD9-41C9-B82C-8AD0402A23E9 wds:Q34140762-9AB20D7E-B03C-4296-9F3F-A5324C0BCD3D wds:Q38815663-028F524D-9ACC-4B81-8A17-3681DE548909 wds:Q77746913-AD8A47D4-2F4D-4024-8BE2-D3E810EDED5B wds:Q33380432-F5BF57BE-9342-4859-B0BD-E394C857377C wds:Q67747775-F3C4D488-DA92-44B8-A5AF-900E0B0400DB

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 171 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software